StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)

Close on Nov 18, 2026Market cap $13.03MP/E –Yield –

Niki BioSolutions price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Niki BioSolutions's price to sales ratio was 121.6× on Jan 31, 2025, against 46.8× a year earlier. Over the last 3 years it ranged from 45.4× to 459.2×, with a median of 125.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 2025121.6×−171.9
2024Dec 31, 2024293.5×+226.0
2023Dec 29, 202367.4×−57.6
2022Dec 30, 2022125.0×–

More Niki BioSolutions figures

See a number that looks wrong?